Nisaurrahmah, N., Sri, O. and Ifora, I. (2021) “Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review”, Journal of Drug Delivery and Therapeutics, 11(1-s), pp. 195–199. doi:10.22270/jddt.v11i1-s.4554.